Sector Watch: Healthcare - Sep 13 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $118.37 +0.87 0.74% | XBI: $95.90 -0.33 -0.34% | Updated Sep 13, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| AMPE Ampio Pharmaceuticals $63.3M |
0.59+0.08 1.5 M |
16% | ||
| XTNT Xtant Medical Holdings $60.2M |
4.58+0.58 111.9 K 8.8x |
15% | ||
| MNLO Menlo Therapeutics $237.1M |
10.32+1.17 637.6 K 3.3x |
13% | ||
| RDHL Redhill Biopharma $680.8M |
8.11+0.65 100.2 K |
9% | ||
| BLPH Bellerophon Therapeutics $70.5M |
1.22+0.09 1.2 M |
8% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| PGNX Progenics Pharmaceuticals $502.7M |
6.00-1.31 5.8 M 3.6x |
-18% | ||
| CVM Cel-Sci $74.9M |
3.18-0.54 2.2 M |
-15% | ||
| VSAR Versartis $51.6M |
1.43-0.12 479.8 K 3.4x |
-8% | ||
| NLNK52WL NewLink Genetics $93.0M |
2.50-0.20 683.4 K |
-7% | ||
| GBT GLOBAL BLOOD THERAPEUTICS $2.2B |
42.55-3.40 1.6 M 2.1x |
-7% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
CLASS ACTION UPDATE for PDD, AMPE and NVRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]Robbins Arroyo LLP: Ampio Pharmaceuticals, Inc. (AMPE) Officers and Directors Breached Their Fiduciary Duties to Shareholders | Business Wire [businesswire.com]
Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404 [globenewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PDD, AMPE, LCI, CBS and PZZA [globenewswire.com]
RedHill Biopharma Announces Positive End-of-Phase II Meeting with FDA on BEKINDA® for IBS-D [globenewswire.com]
Lifshitz & Miller LLP Announces Investigation of American Express Company, GDS Holdings Limited, Lannett Company, Inc., Mednax, Inc., Menlo Therapeutics Inc., Papa John's International, Inc., Tetraphase Pharmaceuticals, Inc. and Zion Oil & Gas, Inc. [prnewswire.com]
Lifshitz & Miller LLP Announces Investigation of Ampio Pharmaceuticals, CV Sciences, Inc., Facebook, Inc., Farmland Partners Inc., LogMeIn, Inc., Nevro Corporation, Sinclair Broadcast Group, Inc. and Tribune Media Company [prnewswire.com]
$3.1 Bn Sickle Cell Disease Market Insights, Epidemiology and Market Forecast 2017-2025 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Ampio Pharmaceuticals, Inc. (AMPE) and Encourages Investors to Contact the Firm [globenewswire.com]
AMPE LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. ? AMPE [globenewswire.com]
GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference [globenewswire.com]
Human Papillomavirus Associated Diseases - Pipeline Insights 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
GBT Announces New Employment Inducement Grants [globenewswire.com]
GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference [globenewswire.com]
RedHill Biopharma Announces Advancement to Second Stage of Phase IIa Study with YELIVA® for Cholangiocarcinoma [globenewswire.com]
NIH Selects CEL-SCI?s LEAPS Rheumatoid Arthritis Vaccine for Commercialization Accelerator Program | Business Wire [businesswire.com]
CLASS ACTION UPDATE for AMPE, LCI and ZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, RMTI, ORCL, AMPE and CBS [globenewswire.com]
RedHill Biopharma Announces Completion of Enrollment for Confirmatory Phase III Study with TALICIA® for H. pylori Infection [globenewswire.com]
Dr. David Bar-Or retires as Chief Scientific Officer of Ampio Pharmaceuticals | Business & Finance | heraldchronicle.com [prnewswire.com]
Medulloblastoma - Pipeline Insight, 2018 - ResearchAndMarkets.com | Business Wire [businesswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
